BECTON, DICKINSON AND COMPANY Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BECTON, DICKINSON AND COMPANY (BDX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 4.00 million shares for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.00M shares, a 300.00% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.00M shares.
- BECTON, DICKINSON AND COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 0.00 shares.
- BECTON, DICKINSON AND COMPANY antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|
| 2025-09-30 | 4.00M shares 10-K · filed 2025-11-25 | |
| 2024-09-30 | 1.00M shares 10-K · filed 2025-11-25 | |
| 2023-09-30 | 0.00 shares 10-K · filed 2025-11-25 | |
| 2022-09-30 | 0.00 shares 10-K · filed 2024-11-27 | |
| 2021-09-30 | 1.00M shares 10-K · filed 2023-11-21 | |
| 2020-09-30 | 1.00M shares 10-K · filed 2022-11-22 | 0.00 shares 10-K · filed 2020-11-25 |
| 2019-09-30 | 0.00 shares 10-K · filed 2021-11-24 | |
| 2018-09-30 | 0.00 shares 10-K · filed 2020-11-25 | |
| 2017-09-30 | 0.00 shares 10-K · filed 2019-11-27 | |
| 2016-09-30 | 0.00 shares 10-K · filed 2018-11-21 | |
| 2015-09-30 | 0.00 shares 10-K · filed 2017-11-22 | |
| 2014-09-30 | 0.00 shares 10-K · filed 2016-11-23 | |
| 2013-09-30 | 0.00 shares 10-K · filed 2015-11-25 | |
| 2012-09-30 | 4.80M shares 8-K · filed 2015-03-13 | |
| 2011-09-30 | 1.20M shares 10-K · filed 2013-11-27 | |
| 2010-09-30 | 1.30M shares 10-K · filed 2012-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |